Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVO) EBITDA: 2009-2025

Historic EBITDA for Evotec SE (EVO) over the last 5 years, with Sep 2025 value amounting to -$52,025.

  • Evotec SE's EBITDA fell 78.81% to -$52,025 in Q3 2025 from the same period last year, while for Sep 2025 it was -$203.3 million, marking a year-over-year decrease of 298.01%. This contributed to the annual value of -$152.3 million for FY2024, which is 197.95% down from last year.
  • As of Q3 2025, Evotec SE's EBITDA stood at -$52,025, which was up 99.97% from -$152.1 million recorded in Q4 2024.
  • Over the past 5 years, Evotec SE's EBITDA peaked at $46.9 million during Q4 2021, and registered a low of -$152.1 million during Q4 2024.
  • In the last 3 years, Evotec SE's EBITDA had a median value of -$40,560 in 2025 and averaged -$33.9 million.
  • Examining YoY changes over the last 5 years, Evotec SE's EBITDA showed a top increase of 438.77% in 2023 and a maximum decrease of 340.30% in 2023.
  • Evotec SE's EBITDA (Quarterly) stood at $46.9 million in 2021, then plummeted by 54.65% to $21.3 million in 2022, then crashed by 340.30% to -$51.1 million in 2023, then crashed by 197.87% to -$152.1 million in 2024, then crashed by 78.81% to -$52,025 in 2025.
  • Its EBITDA was -$52,025 in Q3 2025, compared to -$152.1 million in Q4 2024 and -$29,095 in Q3 2024.